Cells Submission Guide: MDPI Process (2026)

Cells is not a stronger version of a subscription cell-biology journal, and it is not a weaker one. It is a different model. MDPI built it around speed and soundness-based review: the editorial question is whether the work is methodologically sound and within scope, not whether it ranks among the most selective findings of the year. That model shapes everything about how you should prepare the package.

Two consequences matter most. First, the scope is deliberately experimental: the journal states a major focus on experimental cytology rather than on clinical and epidemiological studies, so a chart-review study or a pure modeling paper is the wrong fit even when it mentions cells. Second, the pre-check is fast and partly template-driven, so completeness is rewarded and incompleteness is punished early. A technically excellent manuscript with a missing data availability statement can be returned before a reviewer ever sees it, while a competent, complete, in-scope study moves quickly.

The unusual upside: Cells publishes communications and technical notes, not just full research articles. A single clean mechanistic result or a new method does not have to be inflated into a multi-figure story to find a home. If your finding is real but narrow, the communication format is a feature, not a downgrade.

The core fit for most submissions is the original research article. It works best when the cellular mechanism is central, the methods are reproducible from the text, and the declarations and image data are complete on first upload.

Ask these questions before you submit:

• is the cellular or molecular mechanism the actual subject of the paper, or is it a downstream label on a clinical, epidemiological, or bioinformatics finding?
• can a reader reproduce the methods from the manuscript and supplementary files alone?
• are the data, ethics, and consent statements complete and specific, or are they still stub text?
• do the figures present image data honestly, with originals you could supply on request?

If the answers are uncertain, the pre-check problem is usually more important than the science problem.

The pre-check editor is answering a short list of questions fast, and the framing matters: Cells editors screen for scope, soundness, integrity, and completeness, in that order, before a single reviewer is invited.

On scope, the editor asks whether the manuscript belongs in an experimental cell-biology journal at all. If the work is really clinical, epidemiological, or computational with a thin cellular wrapper, it is redirected or returned. On soundness, the question is whether the methods are reproducible and the analysis appropriate. Cells does not require the finding to be field-defining, but it does require the work to be done correctly and reported in full.

On integrity, the editor checks image data, plagiarism, and the data availability statement. MDPI runs integrity and similarity checks at pre-check, and image-handling problems (undisclosed splices, reused panels, over-processed blots) trigger fast returns. On completeness, the editor looks for the declarations block. A manuscript missing Author Contributions, Funding, a Data Availability Statement, or Conflicts of Interest reads as not ready, even when the science is fine.

Manuscript structure: Cells expects a defined section set: Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusions, plus the declarations block. The abstract runs to roughly 200 words and should make the cell-biology question and the main result both visible, because the abstract is the first thing the pre-check editor reads. Provide 3 to 10 keywords.

Reporting and methods readiness: Provide full experimental detail so results can be reproduced. For animal work, follow ARRIVE; for human-subjects studies, supply ethics and consent specifics; for any quantitative imaging or flow cytometry, state replicate number, statistical test, and how cells or fields were sampled. A figure that quantifies a phenotype without stating n, the test, and the sampling rule is the most common reviewer-stage friction point in cell biology.

Declarations and ethics: Draft the Institutional Review Board statement, Informed Consent statement, Author Contributions (by initials), Funding, Data Availability, and Conflicts of Interest sections before you upload. These are not post-acceptance paperwork at MDPI; they are pre-check gates.

Figures, supplementary, and image assets: A graphical abstract is optional but commonly used; if supplied, it should be a high-resolution PNG, JPEG, or TIFF at a minimum of 560 by 1100 pixels. Figures should be supplied at a minimum of 1000 dpi for line art. Keep uncropped original blots and microscopy fields available, because MDPI may request raw image data during pre-check. ORCID is expected for the submitting author, and the system will ask for suggested reviewers.

In our pre-submission review work with Cells manuscripts, three failure patterns generate the most consistent pre-check returns and reviewer friction, and they are testable against your own manuscript before you upload. Across our cell-biology and molecular-biology pre-submission reviews, the pattern that surprises authors most is that the Cells pre-check is not a quality filter in the Cell Press or Nature sense; it is a scope-and-completeness filter.

The manuscripts that get returned fastest are rarely bad science. They are competent studies whose scope angle, data statement, or image integrity is not ready for a fast, template-driven screen. Manuscripts coming through pre-submission review for Cells split cleanly along these three lines.

Scope-thin cell-biology framing the editor cannot place as experimental cytology

The single most common pattern we see is a manuscript whose cell-biology relevance is downstream rather than central. The study is really a clinical, epidemiological, bioinformatics, or general-biochemistry paper, and a cell line, a Western blot, or a TCGA-style dataset has been added so the work can target a cell-biology journal.

Cells states a major focus on experimental cytology rather than clinical and epidemiological studies, so the pre-check editor has to confirm that the cellular mechanism is the actual subject. When the cell-biology question is not central, the scope assignment fails and the paper is returned or redirected fast.

The testable version of this failure: read your own abstract and introduction, and ask whether an editor could name the cellular process under study from the first paragraph alone. If the cell-biology angle only appears in the discussion, or only as a future application, the framing is too thin for the pre-check, and the fix is to rebuild the introduction and abstract around the cellular mechanism rather than around the disease or the dataset.

Check whether your Cells scope angle reads as experimental cytology from the abstract

Image data and a data availability statement that fail integrity screening

The second pattern is image data or a data statement that cannot survive MDPI's integrity screen. We repeatedly see Western blots with undisclosed splices, microscopy panels reused across figures, flow plots with no gating shown, and a Data Availability Statement that reads only "data available on request" with no repository, accession, or concrete access route.

MDPI treats image integrity and the Data Availability Statement as pre-check gates, not as paperwork to finalize after acceptance, and it may request uncropped originals before review. Because the pre-check is fast, a single integrity flag or a stub data statement can return the manuscript before review.

The testable version: for every blot and microscopy figure, confirm you have the uncropped original and have disclosed any splice or adjustment, and confirm your Data Availability Statement names where the underlying data and raw images actually live.

Check whether your Cells image data and data statement are ready for integrity screening

Quantitative figures that omit replicates, statistics, and sampling rules

The third pattern shows up at the reviewer stage rather than pre-check, and it is quantitative cell-biology data reported without the structure a reviewer needs. A phenotype quantified across an unstated number of cells, a bar chart with no statistical test named, microscopy "representative images" with no sampling rule, or a knockdown experiment with no rescue control: each one forces reviewers to spend their attention on missing structure rather than on the biology.

In cell biology, where claims hinge on reproducibility and appropriate controls, this is the highest-leverage fix before submission. The testable version: for every quantitative figure, state n (cells, fields, or independent experiments), name the statistical test, describe how the data were sampled, and confirm the obvious controls (loading, rescue, isotype, vehicle) are present. If a reviewer cannot tell how many independent experiments support a claim, the reporting is not ready.

Check whether your Cells figures report replicates, statistics, and controls

Each of these is something you can check against your own draft before you commit the submission. This guide tells you what Cells editors look for; the review tells you whether YOUR paper passes the pre-check before you upload. We have reviewed 90+ manuscripts targeting cell-biology and molecular-biology journals, including Cells and its open-access peers, in our Manusights pre-submission review work.

Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts. Run a Cells submission package check to see whether your scope framing, declarations block, and image-integrity readiness will clear the MDPI pre-check.

Cells reports a median first decision near 15.5 days and median acceptance-to-publication near 2.8 days. Treat these as planning ranges, not promises: mechanism-heavy and imaging-heavy manuscripts often run longer because finding specialist reviewers in a narrow subfield takes time.

• Day 0: Submission via SuSy. The portal accepts the package and routes it to an Academic Editor for pre-check.

• Days 1 to 3: Editorial pre-check. The editor screens scope fit, declarations completeness, image integrity, similarity checks, and basic soundness.

The fastest returns happen here, before any reviewer is invited.

• Days 3 to 7: Reviewer invitation. Manuscripts that pass pre-check enter single-blind reviewer search, targeting at least two independent reviewers in the relevant cell-biology subfield.

• Days 7 to 16: Peer review and first decision. Reviewer reports return and the Editor issues the first decision, with a median near 15.5 days from submission.

Major revision is the most common outcome for papers that clear pre-check.

• Days 16 to 30: Revision and acceptance. Revisions are usually requested on a short clock; resubmission and a second review cycle commonly land acceptance inside a few weeks for in-scope, complete packages.

• Days 30 to 33: Production and publication. Acceptance to publication runs near 2.8 days at median, so the slow part of the calendar is reviewer search and revision, not production.

The fast, soundness-based model is a feature for most authors, but it is honest to name when it is a drag. The MDPI pre-check is unforgiving of incompleteness in a way a slower subscription journal is not: a missing data statement that a traditional editor might have queried by email simply becomes a fast return here. The single-blind model means reviewers see your identity, which some authors prefer to avoid.

And the open-access APC of CHF 2,700 is a real budget line that a subscription venue does not charge. If your work needs the prestige halo of a highly selective brand, or your funder will not cover an APC, the speed is not worth the trade. The model rewards complete, in-scope, mid-impact cell-biology work and punishes incomplete packages and scope-stretches faster than a slower journal would.

This guide was researched and built from primary sources: the sources we checked include the Cells Instructions for Authors, the journal's aims-and-scope and editorial-process pages, MDPI's research and publication ethics policy, and Manusights pre-submission review patterns from cell-biology manuscripts deciding between Cells and peer open-access and society journals. We reviewed and compared current MDPI author guidance with recent Manusights work reviews from authors weighing Cells, Journal of Cell Biology, Molecular Biology of the Cell, Cellular and Molecular Life Sciences, and iScience. Last reviewed by the Manusights molecular and cell biology editorial team on 2026-06-07.

Source limitations: MDPI can update APC, article-format details, abstract caps, and editorial-process numbers after this review date, so verify final administrative details against the official Cells author pages before upload. Median timelines are reported by the journal and vary by subfield. Use this guide for the decision the official instructions cannot answer: whether your scope framing, declarations block, and image-integrity readiness are ready for the MDPI pre-check.

• Cells journal hub
• Best cell biology journals
• Best molecular biology journals
• Journal of Cell Biology submission guide
• Cellular and Molecular Life Sciences submission guide
• International Journal of Molecular Sciences submission guide

Before you upload, run your manuscript through a Cells submission readiness check to catch the scope, data, and image-integrity gaps the MDPI pre-check filters for. The check is free to run (/ai-review) and takes a single upload.